Latest S-1 registration statements

WiSA Technologies launches a best-efforts offering of up to 100 million units to repurchase preferred stock and for general corporate purposes.

Inspire Veterinary Partners aims to register the resale of up to 7,869,182 shares of Class A common stock by Tumim Stone Capital LLC, potentially raising up to $30 million.

BIOLASE, Inc. plans to offer units and warrants in a best-efforts offering to raise capital for working capital and general corporate purposes.

Abacus Life, Inc. announces an offering of $15 million in 9.875% Fixed Rate Senior Notes due 2028 to refinance debt and for general corporate purposes.

Helix Acquisition Corp. II files a registration statement to offer an additional 1,150,000 Class A ordinary shares.

SeqLL Inc. plans to raise $20 million through a unit offering to facilitate its merger with Lyneer Investments LLC, a national staffing firm.

Nuwellis, Inc. has filed Amendment No. 3 to its Form S-1 registration statement, primarily to include an updated Exhibit 5.1, with no other changes to the prospectus.

XBP Europe Holdings has filed an amendment to its registration statement, detailing the potential resale of a significant portion of its common stock and warrants by selling securityholders.

YouneeqAI Technical Services is registering 35,814,742 shares of common stock for resale by existing shareholders, aiming to provide liquidity in the OTC market.

WiSA Technologies launches a best-efforts offering of up to 100 million units, aiming to raise approximately $9 million for debt repurchase and general operations.

Evoke Pharma is seeking to raise capital through a public offering of common stock units and pre-funded warrant units to fund operations and commercialization activities.

Wetouch Technology Inc. files an exhibit-only amendment to its Form S-1 registration statement to update and file Exhibit 23.1.

Remark Holdings has filed an amendment to its Form S-1 registration statement, potentially allowing the resale of up to 20 million shares of its common stock by a selling stockholder.

Cyclacel Pharmaceuticals is filing an amendment to its S-1 registration statement to allow selling security holders to resell up to 411,969 shares of common stock issuable upon the exercise of outstanding warrants.

Agrify Corporation, a provider of cultivation and extraction solutions for the cannabis industry, has filed an amended S-1 registration statement with the SEC for a public offering aimed at raising approximately $3 million, as the company navigates financial uncertainties and seeks to regain compliance with Nasdaq listing requirements.

Dianthus Therapeutics amends its S-1 registration statement to register the resale of up to 21,326,988 shares of common stock by selling stockholders.

Expion360 files an amendment to its Form S-1 registration statement to allow for the potential resale of up to 1,781,978 shares of common stock by Tumim Stone Capital, LLC, under a previously established equity line purchase agreement.

Metagenomi, Inc., a precision genetic medicines company, files an amendment to its S-1 registration statement, aiming to raise approximately $100 million in an initial public offering and list its common stock on the Nasdaq Global Select Market under the symbol 'MGX'.

Airship AI Holdings, Inc. registers for resale a mix of common stock and warrants by selling securityholders, along with shares issuable upon exercise of public warrants.

Calidi Biotherapeutics seeks to raise up to $24 million through a public offering of common stock and warrants to advance its stem cell-based oncolytic virus platforms.

ARK 21Shares Ethereum ETF files an amendment to its registration statement for a proposed ETF seeking to track the performance of ether.

BIOLASE aims to raise capital by offering units and pre-funded units, each including common stock or warrants and Class A and Class B warrants.

CytoDyn Inc. has filed an S-1 registration statement with the SEC to allow selling stockholders to resell up to 141,019,099 shares of common stock, including shares underlying warrants.

Helix Acquisition Corp. II, a blank check company, aims to raise $150 million through an initial public offering to pursue a business combination within the healthcare industry.

Massimo Group, a Nevada-based powersports and boat manufacturer, has filed an amendment to its Form S-1 registration statement for an initial public offering of 1,300,000 shares of common stock.

Chromocell Therapeutics updates its S-1/A filing for an initial public offering, aiming to list on the NYSE American under the symbol CHRO.

Safe & Green Holdings Corp. plans to offer shares of common stock, Series A and B warrants, and pre-funded warrants to raise up to $15.25 million for working capital and general corporate purposes.

Aclarion Inc. plans to offer units consisting of common stock or pre-funded warrants and common warrants to raise approximately $7 million in a best-efforts offering.

Rare Element Resources is launching a rights offering to raise approximately $35.8 million to fund the advancement of its Bear Lodge REE Project and for general corporate purposes.

Royalty Management Holding Corporation files an amendment to its registration statement for the offer and sale of Class A Common Stock and warrants by selling securityholders.